336 results
Page 11 of 17
6-K
EX-99.1
u1hgcinvdqwzuexpzr
1 May 12
Live Filing
12:00am
6-K
EX-99.1
au6q5y15
27 Apr 12
Live Filing
12:00am
6-K
EX-99.1
scrlb33zix80 ckks3
20 Apr 12
Teva Announces Pricing of EUR 1 Billion and CHF 450 Million of Senior Notes, and the Closing of a New JPY 100 Billion Unsecured Syndicated Facility
12:00am
6-K
EX-99.1
k6b3gmwp6sec 20c
18 Apr 12
Teva Announces New Data on Central Nervous System Products to Be Presented at 2012 American Academy of Neurology Annual Meeting
12:00am
6-K
EX-99.1
atdztbs
5 Apr 12
Live Filing
12:00am
6-K
EX-99.1
re4lusvhtr
4 Apr 12
Teva Provides Litigation Update
12:00am
6-K
EX-99.1
i9v5vyxf8bkpz27e
28 Mar 12
Teva Announces Launch of Generic Seroquel® in the United States
12:00am
6-K
EX-99.1
7hdw02t
21 Mar 12
Live Filing
12:00am
6-K
EX-99.1
hqtk3 jkimjnv2
16 Mar 12
Live Filing
12:00am
6-K
EX-99.1
wqs 9pcoq
14 Mar 12
Teva Announces Launch of Generic Lexapro® in the United States; Awarded 180-Day Period of Marketing Exclusivity
12:00am
6-K
EX-99.1
7wyc1n
8 Mar 12
Teva Receives FDA Approval for ProAir® HFA (albuterol sulfate) with Dose Counter
12:00am
6-K
EX-99.1
e7p 6h28pvhaeg3
8 Mar 12
Teva and OncoGenex Announce Updates to Custirsen Development Program in Advanced Prostate Cancer
12:00am
6-K
EX-99.1
bph86myou8lv21pzm5m
5 Mar 12
Late Stage Data Demonstrated Long-Term Nasal Symptom Relief and Improvement in Quality of Life
12:00am
6-K
EX-99.1
kmoj3d7iyim 3unbqr
2 Mar 12
Teva Announces Launch of Generic Prometrium® Capsules in the United States
12:00am
6-K
fa4d1a 8fn
15 Feb 12
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
EX-99.1
wyz 7zj7ob8ts69h1
3 Jan 12
Teva Announces Management Succession
12:00am
6-K
EX-99.1
4odl0r
3 Jan 12
Live Filing
12:00am
6-K
EX-99.1
8kax9gwh xj1i
21 Dec 11
Teva Provides 2012 Non-GAAP Financial Outlook; 2012 Non-GAAP Diluted EPS of $5.48 to $5.68
12:00am
F-3ASR
g4dcgh efd
9 Dec 11
Automatic shelf registration (foreign)
12:00am